EUVIMEDEUVIMED entdecken
Crossref

Effect of Scutellarin on the Pharmacokinetics and Pharmacodynamics of Warfarin in Rats

Jiahui Sun iD, Mengnan Qin, Lin Wei, Xuepeng Shi, Bing Shao, Gaofeng Liu, Chunjuan Yang

Planta Medica · 01.04.2026 · 92 (05) · 567-573

DOI: 10.1055/a-2748-8868 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.04.2026. Verfasst von Jiahui Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Apigenin, Glucuronates, Warfarin, Anticoagulants. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Key Research and Development Project of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study aims to investigate the pharmacodynamics and pharmacokinetics to elucidate the mechanism of enhanced anticoagulant effect of scutellarin and its preparations on warfarin. Evaluation of pharmacodynamic effects is undertaken by measuring coagulation parameters prothrombin time (PT) and activated partial thromboplastin time (APTT). The UHPLC-ESI-MS/MS method is used to determine the plasma concentrations of R/S-warfarin to investigate the influence on the pharmacokinetics. Changes in the plasma protein binding rate of warfarin is studied by ultrafiltration. The results of pharmacodynamics showed that there was no significant difference in PT, international normalized ratio (INR), and APTT between the scutellarin control and the blank control group. Compared to the warfarin control group, scutellarin co-administered with the warfarin group has a significant increase in PT and INR after 8 h, and APTT had no change. The pharmacokinetic results showed that there was an increase in peak concentration (C max) and area under curve (AUC 0-t and AUC 0–∞) and a significant prolongation of half time (t 1/2) and a decrease in apparent clearance (CL/F) of R-warfarin compared with the warfarin control group. Compared with the warfarin group, the protein binding rates were decreased in all doses of scutellarin co-administered with the warfarin groups, respectively. Scutellarin can enhance the anticoagulant effect of warfarin by both inhibition of the R-warfarin metabolism and reduction in the protein binding rate of warfarin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApigeninGlucuronatesWarfarinAnticoagulantsAnimalsMaleRatsRats, Sprague-DawleyProthrombin TimePartial Thromboplastin TimeTandem Mass SpectrometryHerb-Drug InteractionsChromatography, High Pressure LiquidInternational Normalized RatioBlood CoagulationArea Under Curve

Substanzen

ApigeninscutellarinGlucuronatesWarfarinAnticoagulants

Autor:innen und Institutionen

  • College of Pharmacy, Harbin Medical University, Harbin, China.
  • Department of Pharmacy, The Second Affiliated Hospital, Harbin Medical University, The Heilongjiang Key Laboratory of Drug Research, Harbin, China.

ORCID-Profile: Jiahui Sun

Förderung

  • Key Research and Development Project of Heilongjiang Province

Zitieren

APA

Sun, J., Qin, M., Wei, L., Shi, X., Shao, B., Liu, G., & Yang, C. (2026). Effect of Scutellarin on the Pharmacokinetics and Pharmacodynamics of Warfarin in Rats. Planta Medica, 92(05), 567-573. https://doi.org/10.1055/a-2748-8868

Vancouver

Sun J, Qin M, Wei L, Shi X, Shao B, Liu G, et al. Effect of Scutellarin on the Pharmacokinetics and Pharmacodynamics of Warfarin in Rats. Planta Medica. 2026;92(05):567-573. doi:10.1055/a-2748-8868

BibTeX
@article{Sun2026,
  author = {Sun, Jiahui and Qin, Mengnan and Wei, Lin and Shi, Xuepeng and Shao, Bing and Liu, Gaofeng and Yang, Chunjuan},
  title = {Effect of Scutellarin on the Pharmacokinetics and Pharmacodynamics of Warfarin in Rats},
  journal = {Planta Medica},
  year = {2026},
  volume = {92},
  number = {05},
  pages = {567--573},
  doi = {10.1055/a-2748-8868}
}
Kostenlos starten →